Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Net Income: 2009-2025

Historic Net Income for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to $338.7 million.

  • UNITED THERAPEUTICS's Net Income rose 9.58% to $338.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 14.47%. This contributed to the annual value of $1.2 billion for FY2024, which is 21.35% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its Net Income stood at $338.7 million for Q3 2025, which was up 9.43% from $309.5 million recorded in Q2 2025.
  • Over the past 5 years, UNITED THERAPEUTICS's Net Income peaked at $338.7 million during Q3 2025, and registered a low of $28.3 million during Q1 2021.
  • Moreover, its 3-year median value for Net Income was $301.3 million (2024), whereas its average is $286.4 million.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Net Income slumped by 79.45% in 2021, and later spiked by 747.70% in 2022.
  • Quarterly analysis of 5 years shows UNITED THERAPEUTICS's Net Income stood at $112.2 million in 2021, then grew by 17.74% to $132.1 million in 2022, then soared by 64.35% to $217.1 million in 2023, then surged by 38.78% to $301.3 million in 2024, then grew by 9.58% to $338.7 million in 2025.
  • Its last three reported values are $338.7 million in Q3 2025, $309.5 million for Q2 2025, and $322.2 million during Q1 2025.